Radiation strategy and techniques for metastatic pleural disease from thymic malignancies: extended abstract
- PMID: 36164364
- PMCID: PMC9385872
- DOI: 10.21037/med-21-61
Radiation strategy and techniques for metastatic pleural disease from thymic malignancies: extended abstract
Conflict of interest statement
Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://med.amegroups.com/article/view/10.21037/med-21-61/coif). “The Series Dedicated to the 11th International Thymic Malignancy Interest Group Annual Meeting (Virtual ITMIG 2021)” was commissioned by the editorial office without any funding or sponsorship. AR reports Consulting Fees: AstraZeneca, Varian Medical Systems, Merck, MoreHealth; and Research Grants: AstraZeneca, Varian Medical Systems, Boehringer Ingelheim, Pfizer, Merck. The authors have no other conflicts of interest to declare.
References
-
- Detterbeck FC, Stratton K, Giroux D, et al. The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol 2014;9:S65-72. 10.1097/JTO.0000000000000290 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources